<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    CTI BioPharma Corp.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About CTI BioPharma Corp.

    CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. In particular, we are focused on evaluating pacritinib for the treatment of adult patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $120,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Adam R. Craig, M.D., Ph.D.
    • FOUNDED
      1991
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrate...

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a Sa...

    Filing Type:    PU
    Premier, Inc.

    Premier, Inc.

    Premier operates one of the nation’s largest performance improvement alliances o...

    Premier operates one of the nation’s largest ...

    Filing Type:    PU
    Genobank.io Inc

    Genobank.io Inc

    Genobank is the first privacy-preserving personal DNA Kit that guarantees consumer...

    Genobank is the first privacy-preserving person...

    Amount Raised:    $156,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical c...

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a...

    Filing Type:    PU
    Apellis Pharmaceuticals, Inc.

    Apellis Pharmaceuticals, Inc.

    We are a clinical-stage biopharmaceutical company focused on the development of no...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Bellerophon Therapeutics, Inc.

    Bellerophon Therapeutics, Inc.

    At Bellerophon Therapeutics, we aim to transform the lives of people suffering fro...

    At Bellerophon Therapeutics, we aim to transfor...

    Filing Type:    PU
    Mustang Bio, Inc.

    Mustang Bio, Inc.

    Mustang Bio, Inc. (“Mustang”), a Fortress Biotech Company, is a clinical-stage...

    Mustang Bio, Inc. (“Mustang”), a Fortress B...

    Filing Type:    PU
    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused o...

    BioXcel Therapeutics, Inc. is a clinical stage ...

    Filing Type:    PU
    Jounce Therapeutics, Inc.

    Jounce Therapeutics, Inc.

    Jounce Therapeutics is a clinical stage immunotherapy company dedicated to transfo...

    Jounce Therapeutics is a clinical stage immunot...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.